News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
696,003 Results
Type
Article (40737)
Company Profile (257)
Press Release (655009)
Section
Business (205203)
Career Advice (2059)
Deals (35567)
Drug Delivery (90)
Drug Development (81077)
Employer Resources (171)
FDA (16178)
Job Trends (14964)
News (346583)
Policy (32676)
Tag
Academia (2611)
Alliances (49698)
Alzheimer's disease (1306)
Approvals (16145)
Artificial intelligence (184)
Bankruptcy (357)
Best Places to Work (11678)
Biotechnology (179)
Breast cancer (215)
Cancer (1592)
Cardiovascular disease (122)
Career advice (1719)
Cell therapy (323)
Clinical research (65115)
Collaboration (610)
Compensation (313)
COVID-19 (2588)
C-suite (143)
Data (1513)
Diabetes (194)
Diagnostics (6346)
Earnings (85300)
Employer resources (148)
Events (111078)
Executive appointments (520)
FDA (16994)
Funding (550)
Gene therapy (224)
GLP-1 (640)
Government (4378)
Healthcare (18844)
Infectious disease (2686)
Inflammatory bowel disease (114)
Interviews (315)
IPO (16462)
Job creations (3713)
Job search strategy (1468)
Layoffs (436)
Legal (7923)
Lung cancer (234)
Manufacturing (223)
Medical device (13320)
Medtech (13325)
Mergers & acquisitions (19412)
Metabolic disorders (514)
Neuroscience (1687)
NextGen: Class of 2025 (6572)
Non-profit (4521)
Northern California (1923)
Obesity (294)
Opinion (193)
Parkinson's disease (112)
Patents (138)
People (57101)
Phase I (20275)
Phase II (28682)
Phase III (21359)
Pipeline (639)
Postmarket research (2568)
Preclinical (8602)
Radiopharmaceuticals (242)
Rare diseases (299)
Real estate (6037)
Regulatory (21970)
Research institute (2386)
Resumes & cover letters (353)
Southern California (1670)
Startups (3622)
United States (17288)
Vaccines (590)
Weight loss (200)
Date
Last 7 days (624)
Last 30 days (2590)
Last 365 days (34779)
2025 (2662)
2024 (35366)
2023 (40252)
2022 (51416)
2021 (55934)
2020 (54413)
2019 (46902)
2018 (35248)
2017 (32447)
2016 (31873)
2015 (37854)
2014 (31619)
2013 (26711)
2012 (28894)
2011 (29577)
2010 (27546)
Location
Africa (735)
Arizona (208)
Asia (37864)
Australia (6172)
California (4411)
Canada (1609)
China (369)
Colorado (199)
Connecticut (210)
Europe (81035)
Florida (634)
Georgia (160)
Illinois (433)
Indiana (251)
Maryland (700)
Massachusetts (3401)
Michigan (188)
Minnesota (323)
New Jersey (1250)
New York (1274)
North Carolina (803)
Northern California (1923)
Ohio (165)
Pennsylvania (1027)
South America (1117)
Southern California (1670)
Texas (647)
Utah (130)
Washington State (438)
696,003 Results for "paladin labs inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Endo’s Paladin Labs Announces Launch of XCOPRI® (cenobamate tablets) in Canada
Paladin Labs Inc., a subsidiary of Endo International plc (OTC: ENDPQ), announced today that XCOPRI® (cenobamate tablets) is now available in Canada.
January 22, 2024
·
7 min read
Press Releases
Endo Announces Agreement for Paladin Pharma to Commercialize Wynzora® Cream in Canada
November 15, 2024
·
4 min read
C3i partners with Paladin Labs Inc. to offer Canadian clinicians a complimentary testing service to detect T315I mutation
C3i Center Inc and Paladin Labs Inc., a subsidiary of Endo International plc, have partnered to launch a complimentary clinical testing program for the diagnosis of the T315I mutation in Philadelphia chromosome-positive chronic myeloid leukemia and acute lymphoblastic leukemia patients in Canada.
June 12, 2023
·
2 min read
Press Releases
MilliporeSigma Partners with Opentrons Labworks, Inc., Supporting Lab of the Future
January 23, 2025
·
5 min read
Press Releases
Know Labs, Inc. Announces $300K Registered Direct Offering
December 13, 2024
·
4 min read
Business
Know Labs, Inc. Reports Second Quarter FY 2024 Results
Know Labs, Inc. (NYSE American: KNW), a leading developer of non-invasive medical diagnostic technology, today reported financial results for the second quarter of the fiscal year 2024 ended March 31, 2024.
May 15, 2024
·
10 min read
Press Releases
ProPhase Labs Inc. to Present Third Quarter 2024 Financial Results on November 13, 2024
November 11, 2024
·
1 min read
Business
Prophase Labs Inc. To Present First Quarter 2024 Financial Results on May 9
ProPhase Labs Inc., announced that they will be presenting first quarter 2024 financial results on a virtual conference call hosted by Renmark Financial on May 9, 2024 at 11:00 am EDT.
May 2, 2024
·
1 min read
Career Advice
12 Careers for Ph.D. Life Scientists Outside of the Lab
Not everyone who completes a life sciences Ph.D. wants to continue working in a laboratory or in research. If this is the case for you, here are 12 careers for Ph.D. life scientists outside of the lab.
November 5, 2024
·
5 min read
·
Mark Terry
Business
Know Labs, Inc. to Host Review of Second Quarter Fiscal Year 2024 Results on May 15, 2024
Know Labs, Inc. today announced it will host a webcast to review business updates and results for its second quarter of the fiscal year 2024 ended on March 31, 2024, on May 15, 2024, beginning at 1:30 pm PT.
May 8, 2024
·
3 min read
1 of 69,601
Next
